Cleared Traditional

K211037 - Vantage Galan 3T

K211037 is the FDA 510(k) clearance for Vantage Galan 3T by Canon Medical Systems Corporation. It is a Class 2 Radiology device (product code LNH) cleared through the Traditional 510(k) pathway after a 40-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2021
Decision
40d
Days
Class 2
Risk

K211037 is an FDA 510(k) clearance for the Vantage Galan 3T, MRT-3020, V6.0 with AiCE Reconstruction Processing Unit for MR. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Canon Medical Systems Corporation (Otawara-Shi, JP). The FDA issued a Cleared decision on May 17, 2021 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Canon Medical Systems Corporation devices

Submission Details

510(k) Number K211037 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 07, 2021
Decision Date May 17, 2021
Days to Decision 40 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 107d · This submission: 40d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Canon Medical Systems USA, Inc.
Janine F. Reyes

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 812
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K211037.
Swoop Point-of-Care Magnetic Resonance Imaging (POC MRI) Scanner System
K211818 · Hyperfine, Inc. · Jul 2021
MAGNETOM Free.Max
K210611 · Siemens Medical Solutions USA, Inc. · Jul 2021
STAGE
K210843 · Spintech, Inc. · Jun 2021
SIGNA 7.0T
K211118 · Ge Medical Systems, LLC · May 2021
TCL3 Motion Tracking System
K203451 · Tracinnovations Aps · Apr 2021
Vantage Orian 1.5T, MRT-1550, V6.0 with AiCE Reconstruction Processing Unit for MR
K210340 · Canon Medical Systems Corporation · Apr 2021